Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas
Open Access
- 4 December 2010
- journal article
- case report
- Published by Springer Nature in Medical Oncology
- Vol. 29 (1) , 127-132
Abstract
Cancers derived from anogenital mammary-like glands are rare, and their identification and selection of treatment for dissemination may be difficult. We encountered two such tumors, which both presented as occult primaries with nodal and hematogenous metastases. They were studied by immunohistochemistry, HER2 receptor assay, and gene expression profiling. Both tumors had some microscopical and immunohistochemical features in common with breast cancer, but lacked estrogen and progesterone receptors. Taxane–platinum-based systemic chemotherapy did not stop progression in a male patient, in whom a developing inguinal skin lesion was the likely primary tumor. The same regimen gave partial remission in a later, female, patient. After the mammary-like, HER2 positive nature of her tumor was confirmed by gene expression profiling using CupPrint and TargetPrint assays, treatment with vinorelbine-trastuzumab induced complete remission that is maintained by trastuzumab alone for almost 4 years after initial diagnosis. Molecular and immunohistochemical characterization of these rare tumors may identify them and sometimes guide systemic chemotherapy away from a non-specific and “broad spectrum” regimen toward a targeted therapy, resulting in greater effectiveness with less side effects.Keywords
This publication has 27 references indexed in Scilit:
- Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast CancerClinical Cancer Research, 2009
- Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown PrimaryJournal of Clinical Oncology, 2008
- Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primaryBritish Journal of Cancer, 2008
- Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2006
- Skin adnexal neoplasms—part 2: An approach to tumours of cutaneous sweat glandsJournal of Clinical Pathology, 2006
- Perianal apocrine adenocarcinoma arising in a benign apocrine adenoma; first case report and review of the literatureJournal of Clinical Pathology, 2005
- Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary‐like glandsJournal of Cutaneous Pathology, 2004
- Prohibitin: A New Biomarker for Breast TumorsThe Breast Journal, 1997
- Adenocarcinoma of the mammary‐like glands of the vulva:Journal of Cutaneous Pathology, 1994
- Mammary-like Glands of the Vulva and Their DisordersInternational Journal of Gynecological Pathology, 1994